Page last updated: 2024-08-23

plicamycin and Cancer of Lung

plicamycin has been researched along with Cancer of Lung in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's6 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bu, Y; Chen, Q; Hu, L; Liu, T; Meng, P; Wang, Y; Zhang, N1
Chen, X; Cunniffe, S; Dianov, GL; Hume, S; Legrand, AJ; Poletto, M; Ramadan, K; Vaz, B; Yao, D1
Kim, HP; Lee, JJ; Park, EY; Park, JH; Park, K; Song, MJ; Yang, WJ1
Arai, J; Matsumoto, K; Miyazaki, T; Mochinaga, K; Nagasaki, T; Nagayasu, T; Nanashima, A; Tominaga, T; Tsuchiya, T; Tsukamoto, K; Yamasaki, N1
Daskalos, A; Field, JK; Gorgoulis, V; Kossida, S; Liloglou, T; Logotheti, S; Michalopoulos, I; Sideridou, M; Spandidos, DA; Vojtesek, B; Zoumpourlis, V1
Chang, WC; Chen, SY; Hsu, TI; Huang, ST; Hung, JJ; Su, WC; Wang, MC; Yeh, YM1
Hisatsune, A; Isohama, Y; Kim, KC; Kuwahara, I; Lillehoj, EP; Lu, W; Miyata, T1
Hsu, CH; Lin, RK; Wang, YC1

Other Studies

8 other study(ies) available for plicamycin and Cancer of Lung

ArticleYear
Sp1 Mediates the Constitutive Expression and Repression of the PDSS2 Gene in Lung Cancer Cells.
    Genes, 2019, 11-27, Volume: 10, Issue:12

    Topics: A549 Cells; Alkyl and Aryl Transferases; Binding Sites; Cell Line, Tumor; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Plicamycin; Prognosis; Promoter Regions, Genetic; Sp1 Transcription Factor; Survival Analysis; Transcription Initiation Site

2019
Interplay between base excision repair protein XRCC1 and ALDH2 predicts overall survival in lung and liver cancer patients.
    Cellular oncology (Dordrecht), 2018, Volume: 41, Issue:5

    Topics: Aldehyde Dehydrogenase, Mitochondrial; Cell Line; Cell Line, Tumor; Cell Survival; DNA Damage; Humans; Liver Neoplasms; Lung Neoplasms; Plicamycin; RNA, Small Interfering; X-ray Repair Cross Complementing Protein 1

2018
Transcription factors Sp1 and Sp3 regulate expression of human ABCG2 gene and chemoresistance phenotype.
    Molecules and cells, 2013, Volume: 36, Issue:4

    Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Binding Sites; Cell Line; Cisplatin; Drug Resistance, Neoplasm; Electrophoretic Mobility Shift Assay; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Lung Neoplasms; Neoplasm Proteins; Plicamycin; Promoter Regions, Genetic; Side-Population Cells; Sp1 Transcription Factor; Sp3 Transcription Factor

2013
Epidermal growth factor signals regulate dihydropyrimidine dehydrogenase expression in EGFR-mutated non-small-cell lung cancer.
    BMC cancer, 2016, 06-06, Volume: 16

    Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Dihydrouracil Dehydrogenase (NADP); Drug Resistance, Neoplasm; Drug Synergism; Epidermal Growth Factor; ErbB Receptors; Fluorouracil; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mutation; Plicamycin; Quinazolines; Signal Transduction; Sp1 Transcription Factor

2016
Sp1 binds to the external promoter of the p73 gene and induces the expression of TAp73gamma in lung cancer.
    The FEBS journal, 2010, Volume: 277, Issue:14

    Topics: Base Sequence; Binding Sites; Cell Line, Tumor; Computational Biology; Conserved Sequence; DNA; DNA-Binding Proteins; Down-Regulation; Electrophoretic Mobility Shift Assay; Humans; Lung Neoplasms; Molecular Sequence Data; Nuclear Proteins; Oligodeoxyribonucleotides; Plicamycin; Promoter Regions, Genetic; Protein Binding; Protein Isoforms; RNA, Small Interfering; Sp1 Transcription Factor; Tumor Protein p73; Tumor Suppressor Proteins; Vascular Endothelial Growth Factor A

2010
Betulinic acid decreases specificity protein 1 (Sp1) level via increasing the sumoylation of sp1 to inhibit lung cancer growth.
    Molecular pharmacology, 2012, Volume: 82, Issue:6

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Betulinic Acid; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin A2; Cysteine Endopeptidases; Down-Regulation; Endopeptidases; Female; HeLa Cells; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Mice, Transgenic; Nuclear Proteins; Pentacyclic Triterpenes; Phosphorylation; Plicamycin; Proteasome Endopeptidase Complex; Retinoblastoma Protein; Sp1 Transcription Factor; Sumoylation; Transcription Factors; Transcriptome; Triterpenes; Ubiquitin; Ubiquitin-Protein Ligases; Xenograft Model Antitumor Assays

2012
Neutrophil elastase stimulates MUC1 gene expression through increased Sp1 binding to the MUC1 promoter.
    American journal of physiology. Lung cellular and molecular physiology, 2005, Volume: 289, Issue:2

    Topics: Adenocarcinoma; Binding Sites; Dactinomycin; Electrophoretic Mobility Shift Assay; Gene Expression Regulation, Neoplastic; Humans; Leukocyte Elastase; Luciferases; Lung Neoplasms; Mucin-1; Plicamycin; Promoter Regions, Genetic; Protein Synthesis Inhibitors; Response Elements; RNA Stability; Sp1 Transcription Factor; Transcription Initiation Site; Transcription, Genetic; Transfection; Tumor Cells, Cultured

2005
Mithramycin A inhibits DNA methyltransferase and metastasis potential of lung cancer cells.
    Anti-cancer drugs, 2007, Volume: 18, Issue:10

    Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Movement; CpG Islands; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Humans; Lung Neoplasms; Models, Molecular; Plicamycin; Promoter Regions, Genetic; Protein Binding

2007